Post-marketing Study of Linagliptin: A Pilot Study

INTRODUCTION: Linagliptin is a high-cost oral antidiabetic that has been widely used, and studies on its effectiveness and safety for the treatment of type 2 diabetes mellitus (DM2) in the real world is rare and necessary. OBJECTIVE: To analyze the values of glycated hemoglobin (HbA1c) and adverse e...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Pharmacol
Hlavní autoři: Gomes, Gabrielle Kéfrem Alves, Pereira, Mariana Linhares, Sanches, Cristina, Baldoni, André Oliveira
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2019
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6543281/
https://ncbi.nlm.nih.gov/pubmed/31178735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00576
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky